TrialAdvances in therapy2017

Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA.

Barnaby Hunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.